Clinical Trial: Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension

U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06964061) titled 'Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension' on March 18.

Brief Summary: The goal of this clinical study is to learn how effective and safe is a single administration of PA5346 Ocular Implant for the reduction of intraocular pressure in adult patients with open-angle glaucoma or ocular hypertension. It will also assess how long it takes for PA5346 Ocular Implant to dissolve in the eye.

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Open Angle Glaucoma (OAG) Ocular Hypertension (OH)

Intervention: COMBINATION_PRODUC...